$LPTX Announces an Investigator-Initiated Study of DKN-01 in Patients with DKK1+ Advanced Prostate Cancer https://finance.yahoo.com/news/leap-therapeutics-announces-investigator-initiated-120000983.html …
Original Article: $LPTX Announces an Investigator-Initiated Study of DKN-01 in Patients with DKK1+ Advanced Prostate Cancer https://finance.yahoo.com/news/leap-therapeutics-announces-investigator-initiated-120000983.html …
NEXT ARTICLE
More From BioPortfolio on "$LPTX Announces an Investigator-Initiated Study of DKN-01 in Patients with DKK1+ Advanced Prostate Cancer https://finance.yahoo.com/news/leap-therapeutics-announces-investigator-initiated-120000983.html …"